Center for Scientific Review; Notice of Closed Meetings, 31194-31196 [2020-11057]
Download as PDF
<![CDATA[
31194
Federal Register / Vol. 85, No. 100 / Friday, May 22, 2020 / Notices
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: Mario Cerritelli, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F58, Rockville, MD
20852, 240–669–5199, cerritem@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 18, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–11059 Filed 5–21–20; 8:45 am]
amended to change the meeting start
time to 9:00 a.m. and end time to 3:00
p.m. This two-day meeting to be held on
June 24–25, 2020 will be a
teleconference meeting. The meeting is
closed to the public.
Dated: May 19, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–11125 Filed 5–21–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
Center for Scientific Review Amended;
Notice of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice is hereby given of a change in
the meeting of the Cardiovascular
Differentiation and Development Study
Section, June 11, 2020, 10:00 a.m. to
June 11, 2020, 07:00 p.m., National
Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD, 20892
which was published in the Federal
Register on May 12, 2020, 85 FR 28022.
This notice is being amended to
change the meeting start time from
11:00 a.m. to 10:00 a.m. The meeting is
closed to the public.
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Electrical Signaling,
Ion Transport, and Arrhythmias Study
Section, June 10, 2020, 10:00 a.m. to
June 10, 2020, 06:00 p.m., National
Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892
which was published in the Federal
Register on May 12, 2020, 85 FR 28022.
This notice is being amended to
change the meeting start time from
11:00 a.m. to 10:00 a.m. The meeting is
closed to the public.
Dated: May 18, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–11058 Filed 5–21–20; 8:45 am]
Dated: May 18, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–11063 Filed 5–21–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Director, National
Institutes of Health; Notice of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee to
the Director, National Institutes of
Health.
The meeting will be held as a
teleconference call only and is open to
the public to dial-in for participation.
Individuals who plan to dial-in to the
meeting and need special assistance or
other reasonable accommodations to do
so, should notify the Contact Person
listed below in advance of the meeting.
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the SINGLE–SITE AND
PILOT CLINICAL TRIALS REVIEW
COMMITTEE, June 24, 2020, 08:00 a.m.
to June 25, 2020, 05:00 p.m., National
Institute of Health (NIH), Rockledge 1,
6705 Rockledge Drive, Bethesda, MD
20892 which was published in the
Federal Register on May 18, 2020, 85
FR 29732. The NHLBI Initial/Integrated
Review Group meeting is being
VerDate Sep<11>2014
18:07 May 21, 2020
Jkt 250001
Dated: May 18, 2020.
Natasha M. Copeland,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–11061 Filed 5–21–20; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
BILLING CODE 4140–01–P
National Institutes of Health
Agenda: ACD to review and approve
concept clearances for the Rapid
Acceleration of Diagnostics (RADx) program
to develop COVID–19 testing technologies,
which is part of NIH’s response to the
COVID–19 pandemic.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892, (Telephone Conference Call), 800–
369–1912, Access Code: 1019627.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–4272, Woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
This notice is being published less than 15
days prior to the meeting due to scheduling
difficulties.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: May 26, 2020.
Time: 1:00 p.m. to 2:00 p.m.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\22MYN1.SGM
22MYN1
Federal Register / Vol. 85, No. 100 / Friday, May 22, 2020 / Notices
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cell Biology
Integrated Review Group; Membrane Biology
and Protein Processing Study Section.
Date: June 15, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Balasundaram,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892, 301–435–
1022, balasundaramd@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Genetic
Variation and Evolution Study Section.
Date: June 22–23, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guoqin Yu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–1276, guoqin.yu@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Genetic
Variation and Evolution.
Date: June 22, 2020.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Emily Foley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, Bethesda, MD 20892, 301–
402–3016, emily.foley@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Biophysical, Physiological,
Pharmacological and Bioengineering
Neuroscience.
Date: June 25–26, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sussan Paydar, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 5222,
Bethesda, MD 20817, (301) 827–4994,
sussan.paydar@nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Biobehavioral Mechanisms of
Emotion, Stress and Health Study Section.
Date: June 25–26, 2020.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
18:07 May 21, 2020
Jkt 250001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Benjamin Shapero, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
Bethesda 20892, (301) 402–4786, shaperobg@
mail.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Integrative Nutrition and Metabolic Processes
Study Section.
Date: June 25–26, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Gregory S. Shelness, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6156,
Bethesda, MD 20892–7892, 301–755–4335,
greg.shelness@nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Auditory System
Study Section.
Date: June 25–26, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Janita N. Turchi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–4005, turchij@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer Drug
Development and Therapeutics.
Date: June 25–26, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lilia Topol, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–451–
0131, ltopol@mail.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Health Services Organization and Delivery
Study Section.
Date: June 25–26, 2020.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacinta Bronte-Tinkew,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892, (301) 806–
0009, brontetinkewjm@csr.nih.gov.
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
31195
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Microbial (non-HIV) Diagnostics
and Detection of Infectious Agents, Food and
Waterborne Pathogens, and Methods in
Microbial Sterilization, Disinfection and
Bioremediation Special Emphasis Panel.
Date: June 25–26, 2020.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808,
Bethesda, MD 20892, 301–435–1167,
pandyaga@mail.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Instrumentation and Systems
Development Study Section.
Date: June 25–26, 2020.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kee Forbes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7806, Bethesda, MD 20892, 301–272–
4865, pyonkh2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Endocrinology, Metabolism,
Nutrition and Reproductive Sciences.
Date: June 25–26, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yunshang Piao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 6184,
Bethesda, MD 20892, 301.402.8402, piaoy3@
mail.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Virology—A Study Section.
Date: June 25–26, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth M. Izumi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3204,
MSC 7808, Bethesda, MD 20892, 301–496–
6980, izumikm@csr.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Cancer Etiology Study Section.
Date: June 25, 2020.
Time: 10:00 a.m. to 7:00 p.m.
E:\FR\FM\22MYN1.SGM
22MYN1
31196
Federal Register / Vol. 85, No. 100 / Friday, May 22, 2020 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ola Mae Zack Howard,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Room 4192, MSC
7806, Bethesda, MD 20892, 301–451–4467,
howardz@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 18, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–11057 Filed 5–21–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 18, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: June 16, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G51,
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: Thomas F. Conway, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G51, Bethesda, MD
20892–9823, 240–507–9685,
thomas.conway@nih.gov.
VerDate Sep<11>2014
18:07 May 21, 2020
Jkt 250001
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: June 18, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G51,
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: Thomas F. Conway, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G51, Bethesda, MD
20892–9823, 240–507–9685,
thomas.conway@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
[FR Doc. 2020–11060 Filed 5–21–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2020–0013; OMB No.
1660–0061]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request; Federal
Assistance to Individuals and
Households Program
Federal Emergency
Management Agency, DHS.
ACTION: 30-Day notice and request for
comments.
AGENCY:
The Federal Emergency
Management Agency (FEMA) will
submit the information collection
abstracted below to the Office of
Management and Budget for review and
clearance in accordance with the
requirements of the Paperwork
Reduction Act of 1995. The submission
will describe the nature of the
information collection, the categories of
respondents, the estimated burden (i.e.,
the time, effort and resources used by
respondents to respond) and cost, and
the actual data collection instruments
FEMA will use.
DATES: Comments must be submitted on
or before June 22, 2020.
SUMMARY:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
should be made to Director, Information
Management Division, 500 C Street SW,
Washington, DC 20472, email address
FEMA-Information-CollectionsManagement@fema.dhs.gov or Brian
Thompson, Supervisory Program
Specialist, FEMA Recovery Directorate,
540–686–3602.
SUPPLEMENTARY INFORMATION: This
proposed information collection
previously published in the Federal
Register on March 11, 2020 at 85 FR
14212 with a 60-day public comment
period. FEMA received three comments
from the public.
Comment 1: The commenter
suggested that FEMA could minimize
the burden for veterans with disabilities
by having their patient advocates or
service organizations asking if they have
any unmet needs. Additionally, the
commenter suggested that when a
disability hinders someone’s ability to
understand things and when those
serious needs have continued to not be
met can deteriorate a service member’s
mental health dramatically. Finally the
commenter stated that when service
members need to apply to many
different organizations and ask for help
only to be advised to contact someone
else without help can be very
discouraging. Rather, a simple phone
call from someone that has access to
important information and the ability to
help that person can really help. FEMA
has initiated interrelated projects to
increase the communication of the
needs of registrants with disabilities
across our programs and better support
the needs of survivors with disabilities.
Recognizing the need for more effective
and actionable disability-related
questions in the Registration Intake form
(covered in OMB collection 1660–0002,
Disaster Assistance Registration), FEMA
is in the process of submitting a revision
to OMB collection 1660–0002 to add a
specific reasonable accommodation
question, and an additional question
capturing disability-related losses. The
reasonable accommodation question
will ask registrants to indicate if they
have a disability-related need to access
FEMA’s programs and services. FEMA’s
ADDRESSES:
E:\FR\FM\22MYN1.SGM
22MYN1
]]>Agencies
[Federal Register Volume 85, Number 100 (Friday, May 22, 2020)]
[Notices]
[Pages 31194-31196]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11057]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant
[[Page 31195]]
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Cell Biology Integrated Review Group;
Membrane Biology and Protein Processing Study Section.
Date: June 15, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Balasundaram, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD
20892, 301-435-1022, [email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Genetic Variation and Evolution Study Section.
Date: June 22-23, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guoqin Yu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 435-1276,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Genetic Variation and Evolution.
Date: June 22, 2020.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Emily Foley, Ph.D., Scientific Review Officer,
Center for Scientific Review, Bethesda, MD 20892, 301-402-3016,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Biophysical, Physiological, Pharmacological and
Bioengineering Neuroscience.
Date: June 25-26, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sussan Paydar, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, RM 5222, Bethesda, MD 20817, (301) 827-4994,
[email protected].
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Biobehavioral Mechanisms of Emotion, Stress
and Health Study Section.
Date: June 25-26, 2020.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Benjamin Shapero, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182, Bethesda 20892, (301) 402-
4786, [email protected].
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Integrative Nutrition
and Metabolic Processes Study Section.
Date: June 25-26, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gregory S. Shelness, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6156, Bethesda, MD 20892-7892,
301-755-4335, [email protected].
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Auditory System Study Section.
Date: June 25-26, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Janita N. Turchi, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402-4005,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Cancer Drug Development and Therapeutics.
Date: June 25-26, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lilia Topol, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-451-
0131, [email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Health Services Organization and Delivery
Study Section.
Date: June 25-26, 2020.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacinta Bronte-Tinkew, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164, MSC 7770, Bethesda, MD
20892, (301) 806-0009, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Microbial (non-HIV) Diagnostics and Detection
of Infectious Agents, Food and Waterborne Pathogens, and Methods in
Microbial Sterilization, Disinfection and Bioremediation Special
Emphasis Panel.
Date: June 25-26, 2020.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gagan Pandya, Ph.D., Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808, Bethesda, MD 20892, 301-435-
1167, [email protected].
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Instrumentation and Systems Development
Study Section.
Date: June 25-26, 2020.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kee Forbes, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5148, MSC 7806, Bethesda, MD 20892, 301-272-
4865, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences.
Date: June 25-26, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yunshang Piao, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institute of Health, 6701
Rockledge Drive, Room 6184, Bethesda, MD 20892, 301.402.8402,
[email protected].
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Virology--A Study Section.
Date: June 25-26, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth M. Izumi, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3204, MSC 7808, Bethesda, MD
20892, 301-496-6980, [email protected].
Name of Committee: Oncology 1--Basic Translational Integrated
Review Group; Cancer Etiology Study Section.
Date: June 25, 2020.
Time: 10:00 a.m. to 7:00 p.m.
[[Page 31196]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Room 4192, MSC 7806, Bethesda, MD 20892,
301-451-4467, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 18, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-11057 Filed 5-21-20; 8:45 am]
BILLING CODE 4140-01-P
